Aalborg University Hospital
Aalborg, 9000, Denmark
Location status: Recruiting
Location contact
Anette A. Højen
CONTACT
Stine F. Lindegaard
CONTACT
NCT Number: NCT06037096
Venous thromboembolism (VTE), clinically presenting as deep vein thrombosis or pulmonary embolism (PE) is the third most frequent cardiovascular disease and is associated with substantial short- and long-term morbidity and mortality and high costs of care. In addition negative physical and mental complications following VTE are common. However in terms of PE, there are no structured follow-up programs in Denmark and there is considerable variation in practice patterns of post-PE management both within and between countries.
This project aims to develop, test and implement a structured follow-up care model for patients with PE (The Attend-PE model). This project is a pre-post intervention study and will estimate the effectiveness of implementing the structured follow-up care model on a national level.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Aalborg, 9000, Denmark
Location status: Recruiting
Anette A. Højen
CONTACT
Stine F. Lindegaard
CONTACT
The pre-post intervention study aims to measure differences in self-reported and clinical outcomes in patients with PE before and after the developed Attend-PE model has been implemented.
For the pre-intervention period, patient-reported questionnaires and registry data will be collected on all persons having received a CT-verified diagnosis of PE in the period March 2022 - May 2023. At 6 and 12 months following the PE event, the patients will receive an online letter with an invitation to complete an online questionnaire. The questionnaire includes validated patient-reported outcome measures and questions about sociodemographic factors. Furthermore, for all patients who have been invited to participate, register data will be retrieved on use of health care services, sick leave, prescription medication, as well as information on hospital of admission. Thus, the last PROM and register data for the 12-month follow-up will be retrieved in May 2024.
From October 2023 - Juni 2024 implementation of the Attend-PE model takes place on a national level, with a project team managing training of personnel and supporting the reorganization of care at the participating hospitals. 16 Danish hospitals have agreed to participate.
Following the implementation of the Attend-PE model, the post-intervention period is initiated. From October 2023 - Juni 2025 a data collection period similar to the pre-intervention period will take place, with patient-reported questionnaires forwarded to patients following a diagnosis of PE at 6 and 12 months, and data from registries being collected in the same time period. Thus, the last 12-month follow-up is expected to be completed in Juni 2026.
Detailed description of Attend-PE model:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A pulmonary embolism follow-up care model consisting of structured elements for follow-up after discharge from hospital.
Other names: A structured post-pulmonary embolism follow-up model
Time frame: 6 and 12 month follow-up
42 item covering health-related quality of life after pulmonary embolism. Transformed scale show score from 0-100, where 0 is the worst outcome and 100 is the best outcome.
Time frame: within the first 6 and 12 months
Patients having redeemed ≥80% of the prescribed anticoagulant medication. Using The Danish National Prescription Registry.
Time frame: 6 and 12 month follow-up
Covering general Health in five dimension. The scores fall on a scale of -0.757 (worst health state) to 1.0 (best health state).
Time frame: 6 and 12 month follow-up
Covering functional status in 5 categories of functional limitations. In total 5 grades of functional limitations, where 1 is the worst grade and 5 is the best grade.
Time frame: 6 and 12 month follow-up
Covering satisfaction with anticoagulant treatment (12-item ACTS Burdens scale and 3-item ACTS Benefits scale). 5-point to 7-point scales, where higher scores indicate higher satisfaction with treatment.
Time frame: 6 and 12 month follow-up
Covering anxiety. Score from 0-3 and total score range from 0 to 21, where 21 is the worst outcome and 0 is the best outcome.
Time frame: 6 and 12 month follow-up
Covering depression. Score from 0-3 and total score range from 0 to 27, where 27 is the worst outcome and 0 is the best outcome.
Time frame: 6 and 12 month follow-up
Covering individual's knowledge, skills and confidence integral to managing one's own health and healthcare on a 4-point likert scale. Transformed scale show score from 0-100, where 0 is the worst outcome and 100 is the best outcome.
Time frame: 6 and 12 month follow-up
Covering work productivity and activity impairment (6 questions). WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity.
Time frame: within the first 6 and 12 months
New hospital admission with a diagnosis of deep vein thrombosis or pulmonary embolism. Using the Danish National Patient registry (DNPR).
Time frame: within the first 6 and 12 months
According to The International Society for Thrombosis and Haemostasis (ISTH) definitions. Using the Danish National Patient registry (DNPR).
Time frame: within the first 6 and 12 months
Death of VTE. Using the Danish Death Register and CPR Registry.
Contact information is provided by the study sponsor or research team.
Anette A. Højen
CONTACT
Stine F. Lindegaard
CONTACT
Aalborg University Hospital
Other
Implementation of a Structured Post-pulmonary Embolism Follow-up Model in a Danish Hospital Setting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07350499
Arterial Thromboembolism, Cardiovascular Diseases
Huntsville, Alabama, United States
View Trial DetailsNCT06041594
Cardiovascular Diseases, Embolism
Birmingham, Alabama, United States
View Trial DetailsNCT06433011
Cardiovascular Diseases, Embolism
Scottsdale, Arizona, United States
View Trial DetailsNCT06588634
Cardiovascular Diseases, Embolism
New Haven, Connecticut, United States
View Trial Details